2022
DOI: 10.1001/jamanetworkopen.2022.36298
|View full text |Cite
|
Sign up to set email alerts
|

Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic

Abstract: ImportanceThe coronavirus disease 2019 (COVID-19) pandemic prompted policy changes to allow increased telehealth delivery of buprenorphine, a potentially lifesaving medication for opioid use disorder (OUD). It is unclear how characteristics of patients who access different treatment modalities (in-person vs telehealth, video vs telephone) vary, and whether modality is associated with retention—a key indicator of care quality.ObjectivesTo compare patient characteristics across receipt of different treatment mod… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

6
50
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(56 citation statements)
references
References 53 publications
6
50
0
Order By: Relevance
“…Notably, these policy changes substantially lowered the barriers for patients to receive MOUD and have thus far not been shown to have negatively impacted patient outcomes, including mortality. 19 , 28 31 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Notably, these policy changes substantially lowered the barriers for patients to receive MOUD and have thus far not been shown to have negatively impacted patient outcomes, including mortality. 19 , 28 31 …”
Section: Discussionmentioning
confidence: 99%
“… 7 Recent national efforts have included the Stepped Care for Opioid Use Disorder Train the Trainer Initiative, increased buprenorphine prescribing through telemedicine, external facilitation provided to low-performing sites, and an initiative to hire clinical pharmacists to address substance use disorders in rural settings. 13 19 …”
mentioning
confidence: 99%
“…37 Finally, one study, among a sample of VHA patients who initiated buprenorphine following COVID-19-related regulatory changes, found higher odds of retention among those who had telehealth visits compared to those who had only in-person visits (odds ratio (OR) 1.31; 95% CI, 1.12-1.53). 36 However, among those who received telehealth, odds of retention was higher among patients who had video visits than only telephone visits (OR: 1.47; 95% CI, 1.26-1.71). 36…”
Section: Telehealth Impact On Buprenorphine Retentionmentioning
confidence: 96%
“…36 However, among those who received telehealth, odds of retention was higher among patients who had video visits than only telephone visits (OR: 1.47; 95% CI, 1.26-1.71). 36…”
Section: Telehealth Impact On Buprenorphine Retentionmentioning
confidence: 96%
See 1 more Smart Citation